NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Treadwell J, Mitchell M, Eatmon K, et al. Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Sep. (Comparative Effectiveness Review, No. 141.)
Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma [Internet].
Show detailsTable 3KQ1a: Summary results of systematic reviews on diagnosis
| Modality | MDCT | EUS-FNA | MRI | PET/CT |
|---|---|---|---|---|
| Number of reviews | 1 | 8, and 4 were high quality | 3 (2 mostly duplicative of each other) | 3 |
| Quality of reviews (based on revised AMSTAR) | Low | 4 Low, 4 High | Low | Low |
| Most recent review | 2005 | 2013 | 2012 | 2013 |
| Range of results | Sensitivity: 91% Specificity: 85% | High quality reviews: Sensitivity: 85% to 93% Specificity: 94% to 100% | Sensitivity: 84% to 86% Specificity: 82% to 91% | Sensitivity: 87% to 90% Specificity: 80% to 85% |
EUS-FNA = Endoscopic ultrasound with fine-needle aspiration; MDCT = multidetector computed tomography; MRI = magnetic resonance imaging; PET/CT = position emission tomography–computed tomography.
- Table 3, KQ1a: Summary results of systematic reviews on diagnosis - Imaging Test...Table 3, KQ1a: Summary results of systematic reviews on diagnosis - Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma
- Homo sapiens LysM, putative peptidoglycan-binding, domain containing 4, mRNA (cD...Homo sapiens LysM, putative peptidoglycan-binding, domain containing 4, mRNA (cDNA clone MGC:46514 IMAGE:5240362), complete cdsgi|26996528|gb|BC041097.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...